Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Cohen Children’s Medical Center ranked No. 1 in New York by US News Reports Northwell Health

Cohen Children’s Medical Center is the top-rated children’s hospital in New York State and has earned top national rankings for exceptional care in nine pediatric specialties, according to US News & World Report’s 2021-2022 Best Children’s Hospitals.

As the largest provider of pediatric health services in the state, Cohen Children’s has been ranked among the nation’s top children’s hospitals by US News for 15 consecutive years.

US News expanded its rankings this year to include state and regional children’s hospital ratings. Cohen Children’s received high marks there as well. In addition to earning the top spot in New York, it was ranked fifth in the mid-Atlantic region, which includes Delaware, the District of Columbia, Maryland, New Jersey, New York, Pennsylvania, Virginia and West Virginia.

Cohen Children’s landed in the top 30 nationally in six disciplines: pediatric urology (ranking 18th), neurology/neurosurgery (21st), pulmonology/lung surgery (tied for 24th), orthopedics (26th), diabetes/endocrinology (27th) and cancer (tied for 30th). The children’s hospital also serves as New York’s largest Level 1 pediatric trauma center and a primary destination for emergency care.

“We are proud to be recognized as the No. 1 children’s hospital in New York and ranked as one of the best hospitals in the nation,” said Michael Dowling, president and CEO of Northwell Health, which operates Cohen Children’s. “This exceptional achievement reflects the unwavering dedication of the staff at Cohen Children’s Medical Center in providing world class care across a broad spectrum of clinical areas to our youngest and most precious patients.”

Coordinated, complex care is a hallmark of Cohen Children’s, which was put to the test during the coronavirus disease 2019 (COVID-19) pandemic. The children’s hospital was a leader in treating children with COVID-19 and helped identify and treat Kawasaki-like disease, the multisystem inflammatory syndrome of childhood (MIS-C), a late-stage response to COVID-19.

“For the past 15 years, our hospital has been ranked among our country’s top children’s  hospitals and all of us are very proud of this ongoing achievement,” said Charles Schleien, MD, MBA, senior vice president and chair of pediatric services at Northwell Health, and the Philip Lanzkowsky Chair and Professor of Pediatrics at the Zucker School of Medicine at Hofstra/Northwell.

He added, “The excellence of every member of our staff – from the surgeons and doctors, nurses and therapists, environmental and food service workers – was put to the test this year as they diligently worked, each in their own way, to care for our patients during the COVID-19 pandemic. In spite of their own personal or family issues, the Cohen Children’s staff cared for these very vulnerable patients in ways that can only be described as heroic. I am so proud of their achievements.”

Below are Cohen Children’s pediatric specialties, as ranked by US News:

* Denotes tie 

To view US News & World Report’s “Best Children’s Hospital’s” edition, go to:


Other hospitals in the news.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

4SC Receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA

Jason Loveridge, Ph.D., CEO of 4SC, commented: “Receiving orphan drug designation for resminostat provides us with a number of important benefits, most crucially 7 years’ market exclusivity in the US, a key foundation of our efforts to commercialise Kinselby.  We are currently preparing a marketing authorisation application for Kinselby in the EU, which remains on track for submission in Q1 2024.”

Abyrx Receives FDA Clearance for MONTAGE ® Settable Bone Putty for Use in Cardiothoracic Surgery

By expanding the range of FDA-cleared surgical applications for MONTAGE, this latest milestone positions Abyrx to build upon the more than 25,000 units of MONTAGE that have been used to date by surgeons in trauma, orthopedics, sports medicine, foot and ankle, and craniomaxillofacial procedures.

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

By using this website you agree to accept Medical Device News Magazine Privacy Policy